WESSON BRUCE F 4
4 · ACURA PHARMACEUTICALS, INC · Filed Jan 2, 2024
Insider Transaction Report
Form 4
WESSON BRUCE F
Director
Transactions
- Disposition to Issuer
Restricted Stock Units (2021 Plan)
2024-01-02−12,500→ 0 total→ Common Stock (0 underlying) - Exercise/Conversion
Common Stock
2024-01-02+37,500→ 829,548 total - Exercise/Conversion
Restricted Stock Units (2021 Plan)
2024-01-02−37,500→ 12,500 total→ Common Stock (37,500 underlying)
Footnotes (7)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vested on the last day of each of March, June, and September 2023. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]25% of the 50,000 Restricted Stock Units granted on January 3, 2023 did not vest and were forfeited due to the departure of the Director in September 2023.